George Cole Jr.

George Cole Jr. is an accomplished medical professional with extensive experience in clinical development and leadership roles within the biopharmaceutical industry. Currently serving as the Head of Late Development and Senior Medical Director at IDEAYA Biosciences, George has also contributed to Certare Ventures, LLP as a Scientific Advisory Board Member. Prior roles include Vice President of Clinical Development at both Nurix Therapeutics and Nuvation Bio, as well as serving as Executive Medical Director at Nektar Therapeutics. George Cole Jr. holds an MD in Medicine from the Yale School of Medicine and a BA in Economics from Yale University.